Abstract
A 56-year-old man with 5-year history of arterial hypertension presents to our office because of asymptomatic abnormalities found in recent routine lab tests. He has been on combination treatment with an ACE-I (lisinopril 20 mg/day) and a diuretic (HCTZ 12.5 mg/day) for the last 2 years. He reports general well-being except for a trend to progressively worse blood pressure control over the last several weeks. He had previously been on dihydropyridine calcium channel blocker (amlodipine 10 mg/day) but had to be switched to current regimen because of side effects (peripheral oedema). His blood pressure has recently been in the range of 150–160 over 85–90 mmHg at home (self-monitored with an automatic oscillometric device at the brachial artery level). Upon interrogation he reports that serum creatinine values have steadily been in the upper normal range for the last 4–5 years.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Herzog CA, Asinger RW, Berger AK, Charytan DM, Díez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach SS, Pun PH, Ritz E. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011;80(6):572–86.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–357.
Viazzi F, Muiesan ML, Schillaci G, Salvetti M, Pucci G, Bonino B, Signori A, Pontremoli R. Changes in albuminuria and cardiovascular risk under antihypertensive treatment: a systematic review and meta-regression analysis. J Hypertens. 2016;34(9):1689–97.
The double challenge of resistant hypertension and chronic kidney disease. Rossignol P, Massy ZA, Azizi M, Bakris G, Ritz E, Covic A, Goldsmith D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Ortiz A, Vanholder R, Wiecek A, Zoccali C, London GM, Stengel B, Fouque D, ERA-EDTA EURECA-m working group, Red de Investigación Renal (REDINREN) network, Cardiovascular and Renal Clinical Trialists (F-CRIN INI-CRCT) network. Lancet. 2015;386(10003):1588–98.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1–130.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Pontremoli, R. (2018). Patient with Hypertension and Reduced Glomerular Filtration Rate. In: Hypertension and Renal Organ Damage. Practical Case Studies in Hypertension Management. Springer, Cham. https://doi.org/10.1007/978-3-319-56408-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-56408-1_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56407-4
Online ISBN: 978-3-319-56408-1
eBook Packages: MedicineMedicine (R0)